We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.89%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+6.16%
1 Year Est. Return
+40.89%
3 Year Est. Return
+115.82%
5 Year Est. Return
+132.07%
10 Year Est. Return
+517.81%
AUM
$109B
AUM Growth
+$10.4B
Cap. Flow
+$4.43B
Cap. Flow %
4.04%
Top 10 Hldgs %
18.72%
Holding
8,634
New
1,445
Increased
2,647
Reduced
3,047
Closed
1,267
Avg Time Held Equity + Options
6.9 quarters
Top 10 Avg Time Held Equity + Options
5.6 quarters
Top 20 Avg Time Held Equity + Options
5 quarters
Avg Time Held Equity only
4.8 quarters
Top 10 Avg Time Held Equity only
1.1 quarters
Top 20 Avg Time Held Equity only
1.1 quarters

Sector Composition

Rank Sector Weight
1 Miscellaneous 56.22%
2 Technology 7.41%
3 Consumer Discretionary 6.04%
4 Financials 5.89%
5 Industrials 4.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
FLY
6576
CALL
DELISTED
Fly Leasing Limited
FLY
$133K ﹤0.01%
+10,100
New +$138K
2017 Q1
0 quarters
BGC icon
6577
PUT
BGC Group
BGC
$5.84B
$132K ﹤0.01%
18,038
-5,287
-23% -$38K
2013 Q2
15 quarters
ISEE
6578
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$132K ﹤0.01%
36,179
-45,087
-55% -$191K
2016 Q4
1 quarter
PCOM
6579
CALL
DELISTED
Points.com Inc. Common Shares
PCOM
$132K ﹤0.01%
+17,100
New +$128K
2017 Q1
0 quarters
KEM
6580
PUT
DELISTED
KEMET Corporation
KEM
$132K ﹤0.01%
11,000
-3,100
-22% -$28.1K
2016 Q4
1 quarter
MCF
6581
CALL
DELISTED
Contango Oil & Gas Co.
MCF
$132K ﹤0.01%
18,000
-1,900
-10% -$14.9K
2016 Q3
2 quarters
BTE icon
6582
PUT
Baytex Energy
BTE
$3.27B
$131K ﹤0.01%
38,300
-26,400
-41% -$103K
2013 Q2
15 quarters
KDNY
6583
CALL
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$131K ﹤0.01%
+2,440
New +$138K
2017 Q1
0 quarters
CZZ
6584
PUT
DELISTED
Cosan Limited
CZZ
$131K ﹤0.01%
+15,300
New +$128K
2017 Q1
0 quarters
I
6585
DELISTED
INTELSAT S. A.
I
$131K ﹤0.01%
+31,613
New +$119K
2017 Q1
0 quarters
DMK
6586
CALL
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$130K ﹤0.01%
436
+236
+118% +$59.5K
2016 Q4
1 quarter
REGI
6587
CALL
DELISTED
Renewable Energy Group, Inc.
REGI
$130K ﹤0.01%
12,400
-4,700
-27% -$43.5K
2016 Q4
1 quarter
GGB icon
6588
PUT
Gerdau
GGB
$10.2B
$129K ﹤0.01%
46,998
-11,970
-20% -$37.2K
2016 Q2
3 quarters
VCYT icon
6589
PUT
Veracyte
VCYT
$3.8B
$129K ﹤0.01%
14,000
-3,700
-21% -$30.3K
2016 Q4
1 quarter
MBT
6590
CALL
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
$129K ﹤0.01%
11,700
-25,200
-68% -$262K
2016 Q3
2 quarters
AEG icon
6591
PUT
Aegon
AEG
$12.6B
$128K ﹤0.01%
32,498
+8,059
+33% +$34.2K
2016 Q4
1 quarter
AGI icon
6592
PUT
Alamos Gold
AGI
$13.6B
$128K ﹤0.01%
15,900
-12,400
-44% -$98.6K
2015 Q2
7 quarters
ARCO icon
6593
CALL
Arcos Dorados Holdings
ARCO
$1.7B
$128K ﹤0.01%
16,342
+2,466
+18% +$15.2K
2013 Q2
15 quarters
GALT icon
6594
CALL
Galectin Therapeutics
GALT
$376M
$128K ﹤0.01%
55,700
+17,100
+44% +$25.8K
2016 Q3
2 quarters
NAK
6595
PUT
Northern Dynasty Minerals
NAK
$731M
$128K ﹤0.01%
89,200
-12,600
-12% -$25.9K
2016 Q3
2 quarters
XPRO icon
6596
Expro Ltd
XPRO
$1.9B
$127K ﹤0.01%
2,008
-169
-8% -$11.9K
2016 Q2
3 quarters
VIVS
6597
VivoSim Labs
VIVS
$2.79M
$127K ﹤0.01%
166
-73
-31% -$57.8K
2016 Q3
2 quarters
BLCM
6598
CALL
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$127K ﹤0.01%
1,030
-950
-48% -$124K
2015 Q1
8 quarters
ZAGG
6599
PUT
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
$127K ﹤0.01%
+17,600
New +$118K
2017 Q1
0 quarters
AXTI icon
6600
AXT Inc
AXTI
$5.65B
$126K ﹤0.01%
21,805
-4,282
-16% -$26.6K
2016 Q3
2 quarters

Similar funds

Citadel Advisors's Q1 2017 Portfolio in Review

As of Q1 2017, Citadel Advisors held 8,634 positions worth $109B, up 11% from $99B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Citadel Advisors deployed $4.43B of net new capital in Q1 2017, opening 1,445 new positions and adding to 2,647 existing holdings. Its largest new stake was Meta Platforms (Facebook): 4,289,917 shares worth $609M.

By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, down from 63% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $482M trimmed.

  • Citadel Advisors's largest Q1 2017 buy was Meta Platforms (Facebook): 4,289,917 shares worth $609M.
  • Citadel Advisors added most to Microsoft in Q1 2017, an estimated $529M increase.
  • Citadel Advisors's biggest Q1 2017 reduction was Alphabet (Google) Class A, cutting an estimated $482M.
  • Citadel Advisors fully exited Celgene Corp in Q1 2017, selling an estimated $341M.
  • Citadel Advisors's ten largest holdings make up 19% of its $109B portfolio in Q1 2017.
  • Citadel Advisors opened 1,445 new positions and closed 1,267 in Q1 2017.
  • Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $109B.

Based on Citadel Advisors's 13F filing for Q1 2017, filed 12 May 2017.